EARLY DIAGNOSIS AND TREATMENT RESEARCH FOUNDATION INC

The Early Diagnosis and Treatment Research Foundation (EDTRF) is a New York–based 501(c)(3) nonprofit that supports research and knowledge development for screening, early diagnosis, and treatment of diseases such as lung cancer, chronic obstructive pulmonary disease, and cardiac disease. It acts primarily as a research-support and convening organization—holding conferences, supporting protocol development and multi-institution research activities, and disseminating results to clinicians and advocacy groups. EDTRF’s leadership includes Dr. Claudia I. Henschke (Principal Officer), who serves as Principal Investigator for the International Early Lung Cancer Action Program (I-ELCAP); the foundation has close working ties to the I-ELCAP network and related screening initiatives. The organization maintains an online presence (edtrf.org) and is listed in public nonprofit databases with EIN 26-4046648 (tax-exempt since 2009). In recent years EDTRF has been active in organizing and supporting international conferences (including meetings on integrating heart and lung low-dose CT screening in 2024 and continuing I-ELCAP meetings into 2025) and in supporting research outputs reflected in high-profile I-ELCAP publications. Recent Form 990 filings report revenue of $151,293 for FY2023 and $210,704 for FY2024, with net assets reported at approximately $615,487 for FY2024, indicating continued fundraising and research-support activity over the past 2–3 years.